Keyphrases
Endoscopy
100%
Crohn's Disease
100%
Microsimulation Model
100%
Cost-effectiveness
100%
Treat-to-target
100%
Monitoring Strategy
71%
Endoscopic Remission
42%
Fecal Calprotectin
28%
Therapeutic Drug Monitoring
28%
Target Monitoring
28%
Diagnostic Performance
14%
Response Pattern
14%
2-way
14%
Patient-level Data
14%
Sensitivity Analysis
14%
Clinical Population
14%
Phase III Clinical Trial
14%
Quality-adjusted Life Years
14%
Colonoscopy
14%
Probabilistic Sensitivity Analysis
14%
Willingness-to-pay Threshold
14%
Transition Probability
14%
Disease Complications
14%
Past Exposure
14%
Outcome-based
14%
Microsimulation
14%
3-way
14%
Exposure-response
14%
Tracker
14%
Probability-based
14%
Cost-effective Approach
14%
History of Surgery
14%
Short-term Costs
14%
Population Estimate
14%
Base-case Model
14%
Medicine and Dentistry
Biological Marker
100%
Crohn's Disease
100%
Cost-Effectiveness Analysis
100%
Endoscopy
77%
Health Care Cost
55%
Faecal Calprotectin
22%
Therapeutic Drug Monitoring
22%
Base
11%
Disease
11%
Clinical Trial
11%
Clinical Population
11%
Diagnostic Performance
11%
Quality Adjusted Life Year
11%
Colonoscopy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Crohn's Disease
100%
Remission
33%
Calgranulin
22%
Therapeutic Drug Monitoring
22%
Base
11%
Disease
11%
Clinical Trial
11%